中国实用妇科与产科杂志

中国实用妇科与产科杂志

• 专题笔谈 • 上一篇    下一篇

新辅助化疗在保留生育功能宫颈癌手术中的应用

侯建青，姜海洋   

  1. 作者单位：烟台毓璜顶医院，山东 烟台 264000
  • 出版日期:2016-09-02 发布日期:2016-09-06

The value of neoadjuvant chemotherapy followed by fertility sparing treatment in patients with cervical cancer.

HOU Jian-qing，JIANG Hai-yang.   

  1. Yantai Yuhuangding Hospital，Yantai 264000，China
  • Online:2016-09-02 Published:2016-09-06

摘要：

宫颈癌发病年龄呈年轻化趋势，未生育的患者比例逐渐上升。保留生育功能的手术已成为治疗早期宫颈癌的标准手术，但适应证严格，获益人群有限。新辅助化疗可以扩大此类手术的适应证，满足患者保留生育功能的目的，且对妊娠无不良影响。

关键词: 宫颈癌, 保留生育功能, 广泛性宫颈切除术, 新辅助化疗

Abstract:

Abstract: The age of patients with cervical cancer is getting younger and younger.Proportion of patients who don’t have a birth is increasing.Fertility sparing surgery has become a standard treatment for the patients with early stage cervical cancer.But the indications are strict，the benifits are limit.Neoadjuvant chemotherapy can enlarge the indication of such the operation and reach the purpose of fertility，it have no adverse effect on the pregnancy.

Key words: cervical cancer, fertility preservation, radical trachelectomy, neoadjuvant chemotherapy

中图分类号: